{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
Japan:Interferon Gamma-1a (Genetical Recombination)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT00375661: Phase 4 Interventional Completed Hepatitis C, Chronic
(2006)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT00172809: Phase 4 Interventional Completed Chronic Hepatitis C
(2005)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT01981083: Phase 4 Interventional Unknown status Protein-Energy Malnutrition
(2013)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT00161616: Phase 4 Interventional Completed Tibial Fractures
(2003)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT04244383: Phase 4 Interventional Unknown status Hepatitis C
(2020)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
Viprinex by Knoll Pharmaceuticals
Source URL:
Class:
PROTEIN
